Delivery Order SPE2DB24D2216-SPE2DB25FGPBC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,721.82 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on June 17, 2025, with completion scheduled for June 18, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order for diabetes medication to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $3,453.76 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) with an ultimate completion date of July 31, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,878.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 19, 2025, with completion scheduled for August 20, 2025. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $18,818.58 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a non-set-aside, competitively awarded contract. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,005.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injectors on June 20, 2025, with completion scheduled for June 23, 2025. This non-set-aside contract represents a small-value pharmaceutical supply delivery to support federal medical procurement needs. The award was made to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen auto-injectors with a ceiling value of $1,162.96 and a completion date of November 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military...
- The Defense Logistics Agency awarded a delivery order valued at $16,483.84 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pen injectors on December 17, 2025, with completion scheduled for December 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,277.30 for Trulicity 1.5 mg/0.5 mL pen injections on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $6,898.33 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen auto-injectors on October 30, 2025, with completion scheduled for October 31, 2025. This firm fixed price contract, placed without a set-aside designation, represents a competitively awarded order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency has awarded a $15,036.20 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA. This delivery order is issued...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPBCDelivery Order
The Defense Logistics Agency awarded a $6,561.71 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injectors on June 24, 2025, with completion targeted for June 25, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a critical vendor for federal military and veteran healthcare procurement through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. This delivery order for Trulicity, a diabetes treatment medication, exemplifies the company's role in supplying specialized pharmaceuticals across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems. The award demonstrates AmerisourceBergen's continued capability to fulfill federal medical supply requirements through open competition as part of its prime vendor relationship with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 6/24/25 |